Download:
pdf |
pdf
Image Description: Centers for Disease Control
Centers for Disease Control
National Center for Environmental Health
Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed partially by Prevention and
Public Health Funds
CDC-RFA-EH17-1701PPHF17
Application Due Date: 04/20/2017
Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed partially by Prevention and
Public Health Funds
CDC-RFA-EH17-1701PPHF17
TABLE OF CONTENTS
Part I. Overview Information
A. Federal Agency Name
B. Funding Opportunity Title
C. Announcement Type
D. Agency Funding Opportunity Number
E. Catalog of Federal Domestic Assistance (CFDA) Number
F. Dates
G. Executive Summary
Part II. Full Text
A. Funding Opportunity Description
B. Award Information
C. Eligibility Information
D. Application and Submission Information
E. Review and Selection Process
F. Award Administration Information
G. Agency Contacts
H. Other Information
I. Glossary
Part I. Overview Information
Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send
Me Change Notifications Emails" link to ensure they receive notifications of any changes to
CDC-RFA-EH17-1701PPHF17. Applicants also must provide an e-mail address to www.grants.gov to
receive notifications of changes.
A. Federal Agency Name:
Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry
(ATSDR)
B. Funding Opportunity Title:
Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed partially by Prevention and
Public Health Funds
C. Announcement Type: New - Type 1
This announcement is only for non-research activities supported by CDC. If research is proposed, the
application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg
/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf. Guidance on how CDC interprets the
definition of research in the context of public health can be found at http://www.cdc.gov/od/science/integrity
/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf.
NCEH – Non-Research/PPHF
D. Agency Funding Opportunity Number:
CDC-RFA-EH17-1701PPHF17
E. Catalog of Federal Domestic Assistance (CFDA) Number:
93.753
Additional CFDA Number:
93.753
F. Dates:
1. Due Date for Letter of Intent (LOI):
2. Due Date for Applications:
N/A
04/20/2017, 11:59 p.m. U.S. Eastern Standard
Time, at www.grants.gov.
3. Date for Informational Conference Call:
The tentative date for the information conference call is March 23, 2017 at 2 p.m. The call will be scheduled
for 1 hour.
Call-in Information:
1-888-606-9927
Leader code - 4706429
Participant code - 9382206
G. Executive Summary:
1. Summary Paragraph:
The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2017
1 of 42
The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2017
funds of approximately $4M from Budget Authority [BA] will be awarded through cooperative agreements
to support childhood lead poisoning prevention activities including: blood lead testing, surveillance, and
targeted population-based interventions. In addition, as part of this FOA, awardees will be expected to
demonstrate that processes are in place to identify lead-exposed children and link them to recommended
services. More specifically, awardees will be expected to work closely with other agencies, partners, other
stakeholders serving children to ensure that a comprehensive system of referral, follow up and evaluation is
in place for lead-exposed children.
a. Eligible Applicants:
Limited
b. FOA Type:
Cooperative Agreement
c. Approximate Number of Awards:
45
10 awards are expected in year 1; 45 awards are expected in years 2&3.
d. Total Project Period Funding:
$35,000,000
e. Average One Year Award Amount:
$400,000
f. Total Project Period Length:
3
g. Estimated Award Date:
09/30/2017
h. Cost Sharing and / or Matching Requirements:
N
No cost sharing or matching funds are required for this program. Although no statutory matching
requirement for this FOA exists, leveraging other resources and related ongoing efforts to promote
sustainability is strongly encouraged.
Part II. Full Text
A. Funding Opportunity Description
Part II. Full Text
1. Background
a. Overview
An estimated 535,000 children in the United States have blood lead levels (BLLs) at or above the reference
value for blood lead established by CDC in 2012 (5 µg/dL). Of these, 150,000 children’s levels are ≥10
µg/dL. These children are at grave risk for the intellectual, behavioral, and academic deficits caused by lead.
The primary source of lead exposed children is their homes; some 38 million homes in the United States
have lead-based paint hazards that can result in childhood lead poisoning. Low-income and minority children
bear a disproportionate burden of this condition caused by unhealthy housing. In addition, some areas of the
United States report that as many as 35% of children identified with high BLLs are exposed to lead via
sources other than lead-based paint in their homes (e.g., such as items decorated or made with lead).
Public health action is needed to support activities to reduce lead exposures, childhood lead poisoning and to
better understand the impact of blood lead levels in children.
b. Statutory Authorities
This program is authorized under Sections 317(k) (2) and 317(B) of the Public Health Service Act (42
U.S.C. Sections 247b (k) (2)] and 247b-3(b)), as amended; Section 4002 of the Patient Protection and
Affordable Care Act of 2010 (ACA), P. L. 111-148, (42 U.S.C. Section 300u-11).
c. Healthy People 2020
2 of 42
The National Center for Environmental Health (NCEH) of CDC within HHS is committed to achieving the
health promotion and disease prevention objectives of “Healthy People 2020” found at https://www.healt
hypeople.gov/ . This FOA is committed to the Healthy People 2020 lead-related goals of reducing: (1) blood
lead above CDC’s current reference level, and (2) mean blood lead levels in young children, as well as
disparities in blood lead levels based on race, ethnicity and socioeconomic status as public health concerns.
This FOA also addresses the Healthy People 2020 focus areas of Maternal, Infant and Child Health, Injury
and Violence Prevention, and Environmental Health.
d. Other National Public Health Priorities and Strategies
This FOA also supports the National Prevention Strategy’s Healthy and Safe Community Environments.
Additional information can be found at https:// www.surgeongeneral.gov/ priorities/ prevention/ strategy/
healthy-and- safe-community-environments.html
e. Relevant Work
The Lead Contamination Control Act of 1988 authorized the Centers for Disease Control and Prevention
(CDC) to initiate program efforts to eliminate childhood lead poisoning in the United States. The CDC
Childhood Lead Poisoning Prevention Program was created as a result of this act.
From 1990 to 2012, CDC awarded funds to State and local health departments to support childhood lead
poisoning prevention programs. In 2009, with congressional acknowledgement, this mission was expanded to
include a healthy homes initiative that addressed multiple childhood diseases and injuries in the home but
with a continued focus on reaching the Health People goal of eliminating childhood lead poisoning.
In 2014, NCEH awarded 3-year funding for lead poisoning prevention programmatic activities under FOA
CDC-RFA-EH14-1408PPHF14. This FOA was financed solely by 2014 Prevention and Public Health Funds.
2. CDC Project Description
a. Approach
Bold indicates project period outcome.
CDC-RFA- EH17-1701PPHF17
Logic Model: Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed
partially by PPHF
Bold indicates project period outcome
Strategies and Activities
Short-term Outcomes
Strengthen blood lead level
testing
Increased numbers of
children less than 6
years (72 months) of
age tested for blood
lead.
Develop and implement
plan for blood lead
testing of children
Strengthen Surveillance
Develop, implement,
and maintain HHLPSS
or equivalent
surveillance system
Long-Term Outcomes
Reduced mean BLL in
children aged less than 6
years (72 months) of age
Improved data usage
that leads to a
greater identification
of geographic areas
and populations at
Reduction of blood
lead in children aged
less than 6 years (72
months) of age
Reduction in housing
3 of 42
Develop and implement
blood lead data
collection, data quality
and dissemination plan
Conduct analysis of
surveillance data
Establish and implement
surveillance reporting
system and
dissemination plan
Strengthen population-based
interventions
Develop and implement
targeted
population-based
interventions
Educate public, partners,
and stakeholders about
lead-related issues
Develop and conduct
trainings for lead
workforce, partners, and
other stakeholders
Develop and maintain
collaborative
relationships with
community, local, and
state partners and
stakeholders to address
priority challenges and
opportunities
high-risk for lead
exposure.
with lead hazards
Increased ability to
target interventions
(e.g. education and
outreach) to
high-risk geographic
areas and
populations.
Increased knowledge
and awareness of
public health
professionals, lead
prevention
workforce, partners,
and other
stakeholders about
lead prevention and
interventions through
lead prevention
training programs.
Improved academic
outcomes for
lead-exposed children
Reduced disparities in
BLL based on race,
ethnicity, or
socio-economic status
Reduced societal costs
associated with
lead-exposures (e.g.
healthcare, special
education, criminal
justice system)
Increased
identification of
children exposed to
lead and linkage to
recommended
services.
Strengthen processes to
identify lead-exposed children
and linkage to services
Provide support and
subject matter expertise
to systems that identify,
refer, provide services
to, and follow
lead-exposed children
Collaborate with
partners, stakeholders,
and programs (e.g.,
early childhood
education programs,
social services, school
4 of 42
systems, etc.) that can
provide services to
mitigate the effects of
high blood lead levels
Connect lead-exposed
children to community
services
Conduct education and
outreach to parents and
providers of
lead-exposed children
i. Purpose
This funding is intended to support activities to reduce lead exposures and lead poisoning.
Activities include: screening, reporting of blood lead data to CDC, data
management/surveillance, and targeted population-based interventions. Awardees will also be
expected to demonstrate that processes are in place to identify lead-exposed children and link
them to recommended services. Awardees will be expected to work closely with agencies,
partners, and other stakeholders serving children to ensure that a comprehensive system of
referral, case management, follow-up and evaluation is in place.
ii. Outcomes
Applicants are expected to achieve and report the following short-term outcomes during the project period:
1. Increase the number of children less than 6 years (72 months) of age tested for blood lead.
2. Improve data usage that leads to a greater identification of geographic areas and populations at
high-risk for lead exposed.
3. Increase the ability to target interventions (e.g. education and outreach) to high-risk geographic areas
and populations.
4. Increase the knowledge and awareness of public health professionals, lead prevention workforce,
partners, and other stakeholders about lead prevention and interventions through lead prevention
training programs.
5. Increase the identification of children exposed to lead and link them to recommended services.
iii. Strategies and Activities
Applicants must use childhood lead poisoning prevention funding to accomplish the following four
activities.
Strengthen Blood Lead Level Testing
In support of blood lead level testing, applicants should:
Develop and implement a plan for increasing blood lead testing of children less than 6 years (72
months) of age.
Develop and implement blood lead testing strategies, with special emphasis on achieving universal
testing of Medicaid-enrolled children.
Strengthen Surveillance
Applicants are expected to implement a childhood lead poisoning surveillance system that can report to
5 of 42
CDC quarterly on the number of children who are exposed to lead in housing, the number of houses that are
identified with lead, and the nature and extent of lead in housing. In addition applicants must:
Develop, implement, and maintain a HHLPSS or equivalent surveillance system that will collect,
compile, and track blood lead data and lead hazards data.
Develop and implement a blood lead data collection, data quality and dissemination plan.
Conduct analyses of surveillance data.
Establish and implement surveillance reporting system and dissemination plan. Include information on
how data will be collected, evaluated, reported, shared with partners, and disseminated to the public.
Strengthen Population-based Interventions
The following are population-based intervention activities that applicants should consider:
Develop and implement targeted population-based interventions.
Educate public, partners, and stakeholders about lead-related issues.
Develop and conduct trainings for lead workforce, partners, and other stakeholders.
Develop and maintain collaborative relationships with community, local, and state partners and
stakeholders to address priority challenges and opportunities.
To assist in the development and implementation of appropriate interventions, collected data shall integrate
or interface with other:
maternal child and environmental public health databases (e.g., immunization registries; Adult Blood
Lead Epidemiology and Surveillance [ABLES]; National Electronic Disease Surveillance System
[NEDSS]; Environmental Public Health Tracking Network; Medicaid; and Special Supplemental
Nutrition Program for Women, Infants and Children [WIC]);
state and local housing and environmental quality authorities; and
housing data including that for housing code enforcement agencies and publicly owned or subsidized
properties and Housing and Urban Development (HUD) collaborative programs.
Strengthen processes to identify lead-exposed children and linkage to services
The following activities should be considered in support of identifying lead-exposed children and linking
them to services:
Provide technical support and subject matter expertise to systems that identify, refer, provide services
to, and follow lead-exposed children.
Organize regular meetings with partners, stakeholders, and programs (e.g., early childhood education
programs, social services, school systems, etc.) that can provide services to mitigate the effects of high
blood lead levels.
Connect lead-exposed children to services.
Conduct education and outreach to parents and providers of lead-exposed children and those who are
considered at-risk.
*The program should ensure that grantees adequately and appropriately inform the public that such
education and outreach (mass communication campaigns) were supported with Federal dollars (if applicable).
*Applicants shall use education and outreach activities to raise awareness about lead-related issues and are
explicitly prohibited from using Federal dollars for lobbying purposes.
1. Collaborations
a. With other CDC programs and CDC-funded organizations:
Applicants should engage other CDC-funded programs in their jurisdictions, particularly those with a focus
6 of 42
Applicants should engage other CDC-funded programs in their jurisdictions, particularly those with a focus
on child health and/or environmental health, and leverage opportunities to reach targeted populations, share
databases, deliver services, and achieve outcomes expected under this FOA. Examples of other CDC-funded
programs include, but are not limited to:
Environmental Public Health Tracking Program
http://www.cdc.gov/nceh/tracking/
National Institute of Occupational Safety and Health’s Adult Blood Lead Epidemiology Program
(ABLES)
https://www.cdc.gov/niosh/topics/ables/
State and local immunization and asthma programs and registries
National Center for Birth Defects and Developmental Disabilities (NCBDDD) programs and registries
b. With organizations not funded by CDC:
Applicants should work with relevant organizations external to CDC that could extend their reach to targeted
populations, interface with other databases, and help facilitate activities under this FOA. Letters of
support/Memorandums of Understanding/Memorandums of Agreement stating agreed upon area of
collaboration from relevant state officials and others should be included in the application.
Examples of such organizations are:
U.S Department of Housing and Urban Development
Center for Medicaid Services (CMS)
Special Supplemental Nutrition Program for Women, Infants and Children (WIC)
EPA
HRSA Title V grantees
HRSA Federal Home Visiting Program
Healthy Start Association
Maternal and child health programs
Early childhood education programs
Community-based, nonprofit and/or faith-based organizations community organizations
State and local health and housing agencies
Private and public laboratories
Hospitals and healthcare systems
Academic Institutions
Department of Energy (Weatherization)
Accredited environmental health practitioners and their organizations
Strategies should be implemented for leveraging resources that include funds from other allowable federally
funded programs and/or state, local, charity, nonprofit or for-profit entities, or internal agency resources.
Applicants are expected to create a capacity-building mechanism, with partners, that will provide training,
education, technical support, mobilization, and consensus to improve the communities’ ability to detect lead
sources and identify risks and provide appropriate and timely interventions.
2. Target Populations
The target population for this program is children less than 6 years (72 months) of age. Priority should be
7 of 42
The target population for this program is children less than 6 years (72 months) of age. Priority should be
given to children disproportionately affected by lead exposures and lead poisoning, particularly those living
in areas that include homes built before 1978, low-income or subsidized housing with suspected or known
lead hazards, racial and ethnic minorities, and recent immigrants.
a. Health Disparities
Applicants should consider underserved populations, including tribal, disabled, and English speakers of other
languages (ESOL), as well as other populations, to ensure they benefit from the applicants’ childhood lead
poisoning prevention activities.
iv. Funding Strategy
Each award is not to exceed $445,000.
b. Evaluation and Performance Measurement
i. CDC Evaluation and Performance Measurement Strategy
Evaluation and progress reports
Prepare a written assessment of the accomplishments, challenges and opportunities including a description of
the problems encountered, lessons learned, potential improvements.
Strategies/Activities:
1) Strengthen Blood Lead Level Testing: Implement a plan for blood lead testing of children less than 6
years (72 months) of age.
Indicators for success: a completed blood lead testing plan that includes an emphasis on universal
testing of Medicaid-enrolled children.
2) Strengthen Surveillance: Implement a surveillance reporting system and dissemination plan. Include
information on how data will be collected, evaluated, reported, shared with partners, and disseminated to the
public.
Indicators for success: establishment and operation of an active ongoing sustainable childhood lead
poisoning surveillance/tracking system in grantees’ jurisdictions that collects person-specific and
address-specific data, including multiple laboratory test results over various years and that assures the
periodic screening of children who are exposed to lead; a completed surveillance plan outlining
approaches for data collection, evaluation, timely reporting, and data sharing to both partners and the
public.
3) Strengthen Population-based Interventions: maintain collaborative relationships with community, local,
and state partners and stakeholders to address priority childhood lead poisoning prevention challenges and
opportunities.
Indicators for success: documentation of ongoing community and partners/stakeholder meetings;
completed examples of lead prevention education and training materials; implementation of a process
that ensures data is received and used by federal agencies and public health officials to target actions to
areas where the risk for childhood lead poisoning is the highest.
4) Strengthen processes to identify lead-exposed children and linkage to services: identify, refer, provide
services to, and follow lead-exposed children.
Indicators for success: implementation of a process that identifies lead-exposed children, provides
guidance for the referral and follow-up care of children, and evaluates the timeliness and efficacy of
these activities.
8 of 42
Outcomes:
1) Increased numbers of children less than 6 years (72 months) of age tested for blood lead.
Indicators for success: Increase in the percentage of children less than 6 years (72 months) of age
tested for blood lead from the previous reporting period; Increase in the percentage of
Medicaid-enrolled children less than 6 years (72 months) of age tested for blood lead since the
previous reporting period.
Percent of Medicaid-enrolled one year-old children tested for blood lead levels during the
reporting period
[calculation: (number of Medicaid-enrolled one year-old children tested for blood lead
levels / total number of Medicaid-enrolled one year-old children in the jurisdiction)*100]
Percent of Medicaid-enrolled two year-old children tested for blood lead levels during the
reporting period
[calculation: (number of Medicaid-enrolled two year-old children tested for blood lead
levels / total number of Medicaid-enrolled two year-old children in the jurisdiction)*100]
Percent of all one and two year-old children (both Medicaid-enrolled and
non-Medicaid-enrolled) tested for blood lead levels in the previous calendar year
[calculation: (number of children aged one and two years tested for blood lead in the
previous calendar year / total number of children under three years of age in the
jurisdiction in the previous calendar year)*100]
2) Improved availability and use of data that leads to improved identification of geographic areas and
populations at high risk for lead exposures.
Indicators for success: 95% of the Awardees' data received by CDC is free of errors and missing
information; the program is able to maintain 100% electronic reporting of blood lead data from
laboratories; resources (e.g., GIS software) and data (e.g., blood lead surveillance, census, and tax
assessor data) are used to analyze and report data.
Percent of laboratory-reported blood lead test results that are reported electronically
[calculation: (number of laboratory-reported blood lead test results that are electronically
reported / total number of laboratory-reported blood lead test results received during the
reporting period)*100]
3) Increased ability to target interventions (e.g. education and outreach) to high-risk geographic areas and
populations.
Indicators for success: community based partners (health care providers, grass roots organizations,
nongovernment organizations [NGOs], others) and/or universities/colleges agree to participate in
preparing for and assisting in population-based surveillance and targeted interventions.
Number of new partner organizations and institutions engaged in brainstorming, strategizing,
planning, implementing, or evaluating interventions for lead poisoning prevention in targeted
geographic areas during the reporting period
Number of new partner organizations and institutions engaged in brainstorming, strategizing,
planning, implementing, or evaluating interventions for lead poisoning prevention for targeted
at-risk populations (to include low-income and immigrant/refugee children) during the reporting
period
Number of regularly scheduled and held meetings with partners and stakeholders during the
reporting period
Number of new memoranda of understanding – or equivalent documents like memoranda of
agreement and joint work plans - related to population-based childhood lead surveillance
enhancement and targeted interventions for lead poisoning prevention developed and signed
during the reporting period
9 of 42
Number of new data-sharing agreements for enhanced population-based childhood lead
surveillance developed and signed during the reporting period
4) Increased knowledge and awareness among the lay public, public health professionals, childhood lead
prevention workforce members, and other partners and stakeholders about childhood lead poisoning and
prevention interventions through tailored education and outreach.
Indicators for success: Increased education on and support for efforts aimed at institutionalizing
primary prevention of childhood lead poisoning through control or elimination of lead sources among
decision makers and the public.
Number of educational outreach events concerning lead poisoning risks and interventions
delivered to the lay public held in targeted high-risk areas during the reporting period
Number of mass communication campaigns directed at the lay public to increase knowledge
and awareness of lead poisoning risks and interventions deployed during the reporting period
Number of educational outreach events – including trainings – directed at public health
professionals, clinical providers, and other lead prevention partners about childhood lead
prevention and interventions held during the reporting period
5) Increased identification of lead-exposed children who receive appropriate linkages to recommended
follow-up services.
Indicators for success: implementation of a process that identifies lead-exposed children, provides
guidance for the referral and follow-up care of children with elevated BLLs, and evaluates the
timeliness and efficacy of these activities.
Number of public health professionals and clinical providers who received guidance documents
for follow-up care for children who are identified with elevated blood lead levels during the
reporting period
Percent of children less than 6 years (72 months) of age who are referred to or from your
Program for recommended follow-up services within two weeks of a confirmed elevated blood
lead test result during the reporting period
[calculation: (number of children with elevated blood lead levels referred for follow-up
services / number of children with elevated blood lead levels)*100]
Percent of children less than 6 years (72 months) of age who received recommended follow-up
services within two weeks of a referral for recommended follow-up services following a
confirmed elevated blood lead test result during the reporting period
[calculation: (number of children with elevated blood lead levels who received referred
follow-up services / number of children with elevated blood lead levels referred for
follow-up services)*100]
ii. Applicant Evaluation and Performance Measurement Plan
Applicants must provide an evaluation and performance measurement plan that demonstrates how the
awardee will fulfill the requirements described in the CDC Evaluation and Performance Measurement and
Project Description sections of this FOA. At a minimum, the plan must describe:
How applicant will collect the performance measures, respond to the evaluation questions, and use
evaluation findings for continuous program quality improvement.
How key program partners will participate in the evaluation and performance measurement planning
processes.
Available data sources, feasibility of collecting appropriate evaluation and performance data, and
other relevant data information (e.g., performance measures proposed by the applicant)
Plans for updating the Data Management Plan (DMP), if applicable, for accuracy throughout the
lifecycle of the project. The DMP should provide a description of the data that will be produced using
10 of 42
these FOA funds; access to data; data standards ensuring released data have documentation describing
methods of collection, what the data represent, and data limitations; and archival and long-term data
preservation plans. For more information about CDC’s policy on the DMP, see
https://www.cdc.gov/grants/additionalrequirements/ar-25.html.
Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed
to:
Describe the type of evaluations (i.e., process, outcome, or both).
Describe key evaluation questions to be addressed by these evaluations.
Describe other information (e.g., measures, data sources).
Awardees will be required to submit a more detailed Evaluation and Performance Measurement plan,
including a DMP, within the first 6 months of award, as described in the Reporting Section of this FOA.
Awardees should provide a statement of commitment to develop and submit a DMP as required by the FOA
prior to the start of data collection in their project narrative.
c. Organizational Capacity of Awardees to Implement the Approach
The organizational capacity statement should describe how the applicant agency is organized to carry out the
requirements of this announcement, the nature and scope of its work, and/or its capabilities. Applicants
should include a detailed description of their experience in collecting, analyzing, and reporting data;
implementing surveillance systems; targeting prevention activities to high risk areas; and managing programs
and staff. They should also describe their working agreements, as well as letters of intent or contracts
with partners.
Applicants should provide an organizational chart and curriculm vitae for key personnel. Key personnel must
have the level of education, experience, and/or skills necessary to successfully implement and complete the
project.
Additional information includes the following:
Organizational chart
Curriculum vitae for existing key personnel (or job descriptions for planned key personnel)
Indirect cost rate agreements
Letters of support
The applicant must create a separate file for the noted items and must name the file "Organizational Chart,”
“CVs/Resumes," “Indirect Cost Rate Agreements,” and “Letters of Support” and upload to www.grants.gov.
d. Work Plan
A work plan is a program management tool that provides program direction and guidance. It
allows the project officer to monitor implementation of activities on progress on project period
outcomes.
Applicants must have a work plan. No specific work plan template is required as long as it is
clear how the components in the work plan crosswalk to the strategies and activities, outcomes,
and evaluation performance measures presented in the logic model and the narrative sections of
this FOA.
A sample work plan format is presented below.
Applicants must provide a separate detailed work plan of no more than 5 pages to describe work
to be conducted in the first year of this award. A high-level work plan of no more than 5 pages
should be included separately to describe work to be conducted in years two and three of the
award.
11 of 42
The table should be completed for each short-term outcome.
Below are 2 examples of filled out templates:
Example #1
Short-term Outcome: [from Outcomes section and/or logic model] Increased number of
children less than 6 years (72 months) of age tested for blood lead
Strategies and
Activities
Process
Direction Baseline Target Responsible
Measure
of Change
Position /
[from
Party
Evaluation
Not started
and
Performance
In
Measurement progress
section]
Completed
1. Develop
Plan for blood Completed
and
lead testing is
implement completed
plan for
blood lead
testing of
children
N/A
Completion
Date
N/A Epidemiologist 09/29/2018
and Program
Manager
Example #2
Short-term Outcome: [from Outcomes section and/or logic model] Increased knowledge and
awareness of public health professionals, lead prevention workforce, partners, and other
stakeholders about lead prevention and interventions through lead prevention training programs
Strategies and
Activities
Process Measure Direction Baseline Target Responsible Completion
[from Evaluation of Change
Position /
Date
and Performance
Party
Measurement
Not
section]
started
In
progress
Completed
1. Develop and
maintain
collaborative
relationships
with
community,
local, and
state
Number of
In
community and
progress
partner/stakeholder
meetings
1
4
Program
Manager
09/29/2018
12 of 42
state
partners and
stakeholders
to address
priority
challenges
and
opportunities
1. Develop and
maintain
collaborative
relationships
with
community,
local, and
state
partners and
stakeholders
to address
priority
challenges
and
opportunities
Number of
Not started
memorandums of
agreement
(MOUs) or signed
null
1
Program
Manager
09/29/2018
e. CDC Monitoring and Accountability Approach
Monitoring activities include routine and ongoing communication between CDC and awardees, site visits,
and awardee reporting (including work plans, performance, and financial reporting). Consistent with
applicable grants regulations and policies, CDC expects the following to be included in post-award
monitoring for grants and cooperative agreements:
Tracking awardee progress in achieving the desired outcomes.
Ensuring the adequacy of awardee systems that underlie and generate data reports.
Creating an environment that fosters integrity in program performance and results.
Monitoring may also include the following activities deemed necessary to monitor the award:
Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.
Ensuring that awardees are performing at a sufficient level to achieve outcomes within stated
timeframes.
Working with awardees on adjusting the work plan based on achievement of outcomes, evaluation
results and changing budgets.
Monitoring performance measures (both programmatic and financial) to assure satisfactory
performance levels.
Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and
specialists, and project officers) in the identification, notification, and management of high-risk grantees.
f. CDC Program Support to Awardees (THIS SECTION APPLIES ONLY TO COOPERATIVE
AGREEMENTS)
CDC will:
13 of 42
CDC will:
Support awardees in the development/enhancement and implementation of their lead poisoning
surveillance programs.
Review the use of data and information collection methods and analysis instruments specific to the use
of CDC HHLPSS.
Provide guidance in implementing activities, and will identify major program issues, strategies, and
priorities related to the cooperative agreement.
Provide technical assistance in assessing program effectiveness.
Promote collaboration with other federal, state, and local health; environmental; and housing agencies
by initiating contacts, conference calls, and on-site visits to discuss programmatic issues.
Provide HHLPSS at no cost, support awardees in deployment of the system and migration of data
from other systems to HHLPPS, and provide ongoing maintenance of the system. (Note: Many states
previously established HHLPSS under CDC-funded cooperative agreements.)
Provide assistance in the evaluation of surveillance activities and reporting and disseminating reports
to partners.
Provide consultation and technical regarding techniques and approaches used to deliver or render
services.
Review the use of data and information collected to support development, enhancement or
implementation of population-based interventions and/or designating areas as lead-safe.
B. Award Information
1. Funding Instrument Type: Cooperative Agreement
CDC's substantial involvement in this program appears in the CDC Program
Support to Awardees Section.
2. Award Mechanism:
UE2
UE2 - Emergency and Environmental Health Services - Cooperative Agreement
3. Fiscal Year:
2017
4. Approximate Total Fiscal $4,000,000
Year Funding:
5. Approximate Project
$35,000,000
Period Funding:
This amount is subject to the availability of funds.
Estimated Total Funding: $35,000,000
6. Total Project Period
3 year(s)
Length:
7. Expected Number of
45
Awards:
10 awards are expected in year 1; 45 awards are expected in years 2&3.
8. Approximate Average
Award:
$400,000 Per Budget Period
9. Award Ceiling:
$445,000 Per Budget Period
This amount is subject to the availability of funds.
$445,000 (If the request is over $445,000, the application will be considered nonresponsive.)
14 of 42
$445,000 (If the request is over $445,000, the application will be considered nonresponsive.)
10. Award Floor:
$150,000 Per Budget Period
11. Estimated Award Date:
12. Budget Period Length:
09/30/2017
12 month(s)
Throughout the project period, CDC will continue the award based on the availability of funds, the evidence
of satisfactory progress by the awardee (as documented in required reports), and the determination that
continued funding is in the best interest of the federal government. The total number of years for which
federal support has been approved (project period) will be shown in the “Notice of Award.” This information
does not constitute a commitment by the federal government to fund the entire period. The total project
period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).
13. Direct Assistance
Direct Assistance (DA) is not available through this FOA.
C. Eligibility Information
1. Eligible Applicants
Eligibility Category:
Others (see text field entitled "Additional Information on Eligibility" for
clarification)
Additional Eligibility Category:
Government Organizations:
State governments or their bona fide agents (includes the District of
Columbia)
Local governments or their bona fide agents
2. Additional Information on Eligibility
This FOA is limited to State Governments or their Bona Fide Agents and Local Governments or their Bona
Fide Agents. Local governments or their Bona Fide Agents must have a valid population size of at least
750,000 using 2010 U.S. Census data or a 2011-2016 U.S. Census data update.
3. Justification for Less than Maximum Competition
This funding opportunity announcement (FOA) is to support a limited competition to State and local
governments or their Bona Fide Agents under the authority of: Sections 317(k) (2) and 317(B) of the Public
Health Service Act (42 U.S.C. Sections 247b (k) (2)] and 247b-3(b)), as amended; Section 4002 of the
Patient Protection and Affordable Care Act of 2010 (ACA), P. L. 111-148, (42 U.S.C. Section 300u-11).
This FOA supports activities related lead poisoning prevention with a focus on using blood surveillance
data to identity and implement appropriate interventions to population at highest risk. Awardees must able
to assure that follow-up is provided for lead-exposed children and/or cases of lead poisoning. Awardees
must have the authority in their jurisdiction(s) to govern, regulate, deliver, implement, and enforce policies,
codes or requirements on childhood lead poisoning prevention that could involve Medicaid, housing,
15 of 42
environmental regulation, or consumer protection agencies. State and local governments or their Bona Fide
Agents are the only entities with these authorities to achieve the mission of this FOA.
4. Cost Sharing or Matching
Cost Sharing / Matching
No
Requirement:
No cost sharing or matching funds are required for this program. Although no statutory matching
requirement for this FOA exists, leveraging other resources and related ongoing efforts to promote
sustainability is strongly encouraged.
5. Maintenance of Effort
Maintenance of effort is not required for this program.
D. Application and Submission Information
1. Required Registrations
An organization must be registered at the three following locations before it can submit an application for
funding at www.grants.gov.
a. Data Universal Numbering System:
All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS
number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as
the Universal Identifier when applying for federal awards or cooperative agreements.
The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free)
or internet at http:// fedgov.dnb. com/ webform/ displayHomePage.do. The DUNS number will be provided
at no charge.
If funds are awarded to an applicant organization that includes sub-awardees, those sub-awardees must
provide their DUNS numbers before accepting any funds.
b. System for Award Management (SAM):
The SAM is the primary registrant database for the federal government and the repository into which an
entity must submit information required to conduct business as an awardee. All applicant organizations must
register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must
be current at all times during which the applicant has an application under consideration for funding by CDC.
If an award is made, the SAM information must be maintained until a final financial report is submitted or
the final payment is received, whichever is later. The SAM registration process can require 10 or more
business days, and registration must be renewed annually. Additional information about registration
procedures may be found at www.SAM.gov.
c. Grants.gov:
The first step in submitting an application online is registering your organization at www.grants.gov, the
official HHS E-grant Web site. Registration information is located at the “Get Registered” option
at www.grants.gov.
All applicant organizations must register at www.grants.gov. The one-time registration process usually takes
not more than five days to complete. Applicants should start the registration process as early as possible.
16 of 42
Step System
1
Data
Universal
Number
System
(DUNS)
2
3
Requirements
1. Click on
http://
fedgov.dnb.com/
webform
2. Select Begin
DUNS
search/request
process
3. Select your
country or
territory and
follow the
instructions to
obtain your
DUNS 9-digit #
4. Request
appropriate staff
member(s) to
obtain DUNS
number, verify
& update
information
under DUNS
number
System for 1. Retrieve
Award
organizations
Management DUNS number
(SAM)
2. Go to
formerly
www.sam.gov
Central
and designate an
Contractor E-Biz POC
Registration (note CCR
(CCR)
username will
not work in
SAM and you
will need to
have an
active SAM
account before
you can register
on grants.gov)
Grants.gov 1. Set up an
individual
account in
Grants.gov
using
organization
new DUNS
number to
Duration Follow Up
1-2
Business
Days
To confirm that you have been
issued a new DUNS number check
online at (http:// fedgov.dnb.com/
webform) or call
1-866-705-5711Image Description:
3-5
For SAM Customer Service
Business Contact https://fsd.gov/ fsd-gov/
Days but home.do Calls:
up to 2
866-606-8220Image Description:
weeks and
must be
renewed
once a year
Same day Register early! Log into grants.gov
but can
and check AOR status until it
take 8
shows you have been approved
weeks to
be fully
registered
and
approved
17 of 42
become an
authorized
organization
representative
(AOR)
2. Once the
account is set up
the E-BIZ POC
will be notified
via email
3. Log into
grants.gov using
the password
the E-BIZ POC
received and
create new
password
4. This
authorizes the
AOR to submit
applications on
behalf of the
organization
in the
system
(note,
applicants
MUST
obtain a
DUNS
number
and SAM
account
before
applying
on
grants.gov)
2. Request Application Package
Applicants may access the application package at www.grants.gov.
3. Application Package
Applicants must download the SF-424, Application for Federal Assistance, package associated with this
funding opportunity at www.grants.gov. If Internet access is not available, or if the online forms cannot be
accessed, applicants may call the CDC OGS staff at 770-488-2700Image Description: or e-mail OGS
ogstims@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY
1-888-232-6348Image Description: .
4. Submission Dates and Times
If the application is not submitted by the deadline published in the FOA, it will not be processed. Office of
Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline.
The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements
section for additional details). If the applicant is authorized to submit a paper application, it must be received
by the deadline provided by OGS.
a. Letter of Intent Deadline (must be emailed or postmarked by)
Due Date for Letter of Intent: N/A
b. Application Deadline
Due Date for Applications: 04/20/2017 , 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If
Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of
an extension, then applications must be submitted by the first business day on which grants.gov operations
resume.
Date for Information Conference Call
18 of 42
The tentative date for the information conference call is March 23, 2017 at 2 p.m. The call will be scheduled
for 1 hour.
Call-in Information:
1-888-606-9927
Leader code - 4706429
Participant code - 9382206
5. CDC Assurances and Certifications
All applicants are required to sign and submit “Assurances and Certifications” documents indicated
at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa)) /Homepage.aspx.
Applicants may follow either of the following processes:
Complete the applicable assurances and certifications with each application submission, name the file
“Assurances and Certifications” and upload it as a PDF file with at www.grants.gov
Complete the applicable assurances and certifications and submit them directly to CDC on an annual
basis at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx
Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all
applications submitted to CDC by the applicant within one year of the submission date.
Duplication of Efforts
Applicants are responsible for reporting if this application will result in programmatic, budgetary, or
commitment overlap with another application or award (i.e. grant, cooperative agreement, or contract)
submitted to another funding source in the same fiscal year. Programmatic overlap occurs when (1)
substantially the same project is proposed in more than one application or is submitted to two or more
funding sources for review and funding consideration or (2) a specific objective and the project design for
accomplishing the objective are the same or closely related in two or more applications or awards, regardless
of the funding source. Budgetary overlap occurs when duplicate or equivalent budgetary items (e.g.,
equipment, salaries) are requested in an application but already are provided by another source.
Commitment overlap occurs when an individual’s time commitment exceeds 100 percent, whether or not
salary support is requested in the application. Overlap, whether programmatic, budgetary, or commitment of
an individual’s effort greater than 100 percent, is not permitted. Any overlap will be resolved by the CDC
with the applicant and the PD/PI prior to award.
Report Submission: The applicant must upload the report in Grants.gov under “Other Attachment Forms.”
The document should be labeled: "Report on Programmatic, Budgetary, and Commitment Overlap.”
6. Content and Form of Application Submission
Applicants are required to include all of the following documents with their application package
at www.grants.gov.
7. Letter of Intent
Letter of intent is not required
8. Table of Contents
(There is no page limit. The table of contents is not included in the project narrative page limit.): The
applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.
Provide a detailed table of contents for the entire submission package that includes all of the documents in
the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and
upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.
19 of 42
9. Project Abstract Summary
(Maximum 1 page)
A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov.
The project abstract must be a self-contained, brief summary of the proposed project including the purpose
and outcomes. This summary must not include any proprietary or confidential information. Applicants must
enter the summary in the "Project Abstract Summary" text box at www.grants.gov.
10. Project Narrative
(Unless specified in the "H. Other Information" section, maximum of 20 pages, single spaced, 12 point font,
1-inch margins, number all pages. This includes the work plan. Content beyond the specified page number
will not be reviewed.)
Applicants must submit a Project Narrative with the application forms. Applicants must name this file
“Project Narrative” and upload it at www.grants.gov. The Project Narrative must include all of the
following headings (including subheadings): Background, Approach, Applicant Evaluation and Performance
Measurement Plan, Organizational Capacity of Applicants to Implement the Approach, and Work Plan. The
Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address
outcomes and activities to be conducted over the entire project period as identified in the CDC Project
Description section. Applicants should use the federal plain language guidelines and Clear Communication
Index to respond to this Funding Opportunity Announcement. Note that awardees should also use these tools
when creating public communication materials supported by this FOA. Failure to follow the guidance and
format may negatively impact scoring of the application.
a. Background
Applicants must provide a description of relevant background information that includes the context of the
problem (See CDC Background).
b. Approach
i. Purpose
Applicants must describe in 2-3 sentences specifically how their application will address the public
health problem as described in the CDC Background section.
ii. Outcomes
Applicants must clearly identify the outcomes they expect to achieve by the end of the project period, as
identified in the logic model in the Approach section of the CDC Project Description. Outcomes are the
results that the program intends to achieve and usually indicate the intended direction of change (e.g.,
increase, decrease).
iii. Strategies and Activities
Applicants must provide a clear and concise description of the strategies and activities they will use to
achieve the project period outcomes. Applicants must select existing evidence-based strategies that meet
their needs, or describe in the Applicant Evaluation and Performance Measurement Plan how these strategies
will be evaluated over the course of the project period. See the Strategies and Activities section of the CDC
Project Description.
1. Collaborations
Applicants must describe how they will collaborate with programs and organizations either internal or
external to CDC. Applicants must address the Collaboration requirements as described in the CDC Project
Description.
20 of 42
2. Target Populations and Health Disparities
Applicants must describe the specific target population(s) in their jurisdiction and explain how such a target
will achieve the goals of the award and/or alleviate health disparities. The applicants must also address how
they will include specific populations that can benefit from the program that is described in the Approach
section. Applicants must address the Target Populations and Health Disparities requirements as described in
the CDC Project Description.
c. Applicant Evaluation and Performance Measurement Plan
Applicants must provide an evaluation and performance measurement plan that demonstrates how the
awardee will fulfill the requirements described in the CDC Evaluation and Performance Measurement and
Project Description sections of this FOA. At a minimum, the plan must describe:
How applicant will collect the performance measures, respond to the evaluation questions, and use
evaluation findings for continuous program quality improvement. The Paperwork Reduction Act of
1995 (PRA): Applicants are advised that any activities involving information collections (e.g.,
surveys, questionnaires, applications, audits, data requests, reporting, recordkeeping and disclosure
requirements) from 10 or more individuals or non-Federal entities, including State and local
governmental agencies, and funded or sponsored by the Federal Government are subject to review and
approval by the Office of Management and Budget. For further information about CDC’s
requirements under PRA see http://www.hhs.gov/ ocio/policy/collection/.
How key program partners will participate in the evaluation and performance measurement planning
processes.
Available data sources, feasibility of collecting appropriate evaluation and performance data, data
management plan (DMP), and other relevant data information (e.g., performance measures proposed
by the applicant).
Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed
to:
Describe the type of evaluations (i.e., process, outcome, or both).
Describe key evaluation questions to be addressed by these evaluations.
Describe other information (e.g., measures, data sources).
Awardees will be required to submit a more detailed Evaluation and Performance Measurement plan
(including the DMP elements) within the first 6 months of award, as described in the Reporting Section of
this FOA.
d. Organizational Capacity of Applicants to Implement the Approach
Applicants must address the organizational capacity requirements as described in the CDC Project
Description.
11. Work Plan
(Included in the Project Narrative’s page limit)
Applicants must prepare a work plan consistent with the CDC Project Description Work Plan section. The
work plan integrates and delineates more specifically how the awardee plans to carry out achieving the
project period outcomes, strategies and activities, evaluation and performance measurement.
21 of 42
12. Budget Narrative
Applicants must submit an itemized budget narrative. When developing the budget narrative, applicants
must consider whether the proposed budget is reasonable and consistent with the purpose, outcomes, and
program strategy outlined in the project narrative. The budget must include:
Salaries and wages
Fringe benefits
Consultant costs
Equipment
Supplies
Travel
Other categories
Contractual costs
Total Direct costs
Total Indirect costs
Indirect costs could include the cost of collecting, managing, sharing and preserving data.
Indirect costs will not be reimbursed under grants to foreign organizations, international organizations, and
foreign components of grants to domestic organizations (does not affect indirect cost reimbursement to the
domestic entity for domestic activities).
For guidance on completing a detailed budget, see Budget Preparation Guidelines at: http:// www.cdc.gov
/grants /interested in applying /application resources.html.
If applicable and consistent with the cited statutory authority for this announcement, applicant entities may
use funds for activities as they relate to the intent of this FOA to meet national standards or seek health
department accreditation through the Public Health Accreditation Board (see: http://www.phaboard.org).
Applicant entities to whom this provision applies include state, local, territorial governments (including the
District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the
Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the
Marshall Islands, and the Republic of Palau), or their bona fide agents, political subdivisions of states (in
consultation with states), federally recognized or state-recognized American Indian or Alaska Native tribal
governments, and American Indian or Alaska Native tribally designated organizations. Activities include
those that enable a public health organization to deliver public health services such as activities that ensure a
capable and qualified workforce, up-to-date information systems, and the capability to assess and respond to
public health needs. Use of these funds must focus on achieving a minimum of one national standard that
supports the intent of the FOA. Proposed activities must be included in the budget narrative and must
indicate which standards will be addressed.
Applicants must name this file “Budget Narrative” and upload it as a PDF file at www.grants.gov. If
requesting indirect costs in the budget, a copy of the indirect cost-rate agreement is required. If the indirect
costs are requested, include a copy of the current negotiated federal indirect cost rate agreement or a cost
allocation plan approval letter for those Grantees under such a plan. Applicants must name this file “Indirect
Cost Rate” and upload it at www.grants.gov.
13. Funds Tracking
Proper fiscal oversight is critical to maintaining public trust in the stewardship of federal funds. Effective
October 1, 2013, a new HHS policy on subaccounts requires the CDC to set up payment subaccounts within
the Payment Management System (PMS) for all new grant awards. Funds awarded in support of approved
activities and drawdown instructions will be identified on the Notice of Award in a newly established PMS
subaccount (P subaccount). Grantees will be required to draw down funds from award-specific accounts in
the PMS. Ultimately, the subaccounts will provide grantees and CDC a more detailed and precise
understanding of financial transactions. The successful applicant will be required to track funds by
P-accounts/sub accounts for each project/cooperative agreement awarded.
22 of 42
Applicants are encouraged to demonstrate a record of fiscal responsibility and the ability to provide
sufficient and effective oversight. Financial management systems must meet the requirements as described 2
CFR 200 which include, but are not limited to, the following:
Records that identify adequately the source and application of funds for federally-funded activities.
Effective control over, and accountability for, all funds, property, and other assets.
Comparison of expenditures with budget amounts for each Federal award.
Written procedures to implement payment requirements.
Written procedures for determining cost allowability.
Written procedures for financial reporting and monitoring.
14. Intergovernmental Review
The application is subject to Intergovernmental Review of Federal Programs, as governed by Executive
Order 12372, which established a system for state and local intergovernmental review of proposed federal
assistance applications. Applicants should inform their state single point of contact (SPOC) as early as
possible that they are applying prospectively for federal assistance and request instructions on the state's
process. The current SPOC list is available at: http://www.whitehouse.gov/omb/grants_spoc/.
15. Pilot Program for Enhancement of Employee Whistleblower Protections
Pilot Program for Enhancement of Employee Whistleblower Protections: All applicants will be subject to a
term and condition that applies the terms of 48 Code of Federal Regulations (CFR) section 3.908 to the
award and requires that grantees inform their employees in writing (in the predominant native language of
the workforce) of employee whistleblower rights and protections under 41 U.S.C. 4712.
16. Copyright Interests Provisions
This provision is intended to ensure that the public has access to the results and accomplishments of public
health activities funded by CDC. Pursuant to applicable grant regulations and CDC’s Public Access Policy,
Recipient agrees to submit into the National Institutes of Health (NIH) Manuscript Submission (NIHMS)
system an electronic version of the final, peer-reviewed manuscript of any such work developed under this
award upon acceptance for publication, to be made publicly available no later than 12 months after the
official date of publication. Also at the time of submission, Recipient and/or the Recipient’s submitting
author must specify the date the final manuscript will be publicly accessible through PubMed Central
(PMC). Recipient and/or Recipient’s submitting author must also post the manuscript through PMC within
twelve (12) months of the publisher's official date of final publication; however the author is strongly
encouraged to make the subject manuscript available as soon as possible. The recipient must obtain prior
approval from the CDC for any exception to this provision.
The author's final, peer-reviewed manuscript is defined as the final version accepted for journal publication,
and includes all modifications from the publishing peer review process, and all graphics and supplemental
material associated with the article. Recipient and its submitting authors working under this award are
responsible for ensuring that any publishing or copyright agreements concerning submitted articles reserve
adequate right to fully comply with this provision and the license reserved by CDC. The manuscript will be
hosted in both PMC and the CDC Stacks institutional repository system. In progress reports for this award,
recipient must identify publications subject to the CDC Public Access Policy by using the applicable
NIHMS identification number for up to three (3) months after the publication date and the PubMed Central
identification number (PMCID) thereafter.
23 of 42
17. Funding Restrictions
Restrictions that must be considered while planning the programs and writing the budget are:
Awardees may not use funds for research.
Awardees may not use funds for clinical care except as allowed by law.
Awardees may use funds only for reasonable program purposes, including personnel, travel, supplies,
and services.
Generally, awardees may not use funds to purchase furniture or equipment. Any such proposed
spending must be clearly identified in the budget.
Reimbursement of pre-award costs generally is not allowed, unless the CDC provides written approval
to the awardee.
Other than for normal and recognized executive-legislative relationships, no funds may be used for:
publicity or propaganda purposes, for the preparation, distribution, or use of any material
designed to support or defeat the enactment of legislation before any legislative body
the salary or expenses of any grant or contract recipient, or agent acting for such recipient,
related to any activity designed to influence the enactment of legislation, appropriations,
regulation, administrative action, or Executive order proposed or pending before any legislative
body
See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance
on lobbying for CDC awardees.
The direct and primary recipient in a cooperative agreement program must perform a substantial role
in carrying out project outcomes and not merely serve as a conduit for an award to another party or
provider who is ineligible.
18. Data Management Plan
As identified in the Evaluation and Performance Measurement section, applications involving data collection
must include a Data Management Plan (DMP) as part of their evaluation and performance measurement
plan. The DMP is the applicant’s assurance of the quality of the public health data through the data’s
lifecycle and plans to deposit data in a repository to preserve and to make the data accessible in a timely
manner. See web link for additional information:
https://www.cdc.gov/grants/additionalrequirements/ar-25.html
19. Other Submission Requirements
a. Electronic Submission: Applications must be submitted electronically at www.grants.gov. The
application package can be downloaded at www.grants.gov. Applicants can complete the application
package off-line and submit the application by uploading it at www.grants.gov. All application attachments
must be submitted using a PDF file format. Directions for creating PDF files can be found
at www.grants.gov. File formats other than PDF may not be readable by OGS Technical Information
Management Section (TIMS) staff.
Applications must be submitted electronically by using the forms and instructions posted for this funding
opportunity at www.grants.gov.
If Internet access is not available or if the forms cannot be accessed online, applicants may contact the OGS
TIMS staff at 770- 488-2700 or by e-mail at ogstims@cdc.gov, Monday through Friday, 7:30 a.m.–4:30
p.m., except federal holidays. Electronic applications will be considered successful if they are available
to OGS TIMS staff for processing from www.grants.gov on the deadline date.
24 of 42
b. Tracking Number: Applications submitted through www.grants.gov are time/date stamped electronically
and assigned a tracking number. The applicant’s Authorized Organization Representative (AOR) will be sent
an e-mail notice of receipt when www.grants.gov receives the application. The tracking number documents
that the application has been submitted and initiates the required electronic validation process before the
application is made available to CDC.
c. Validation Process: Application submission is not concluded until the validation process is completed
successfully. After the application package is submitted, the applicant will receive a “submission receipt”
e-mail generated by www.grants.gov. A second e-mail message to applicants will then be generated
by www.grants.gov that will either validate or reject the submitted application package. This validation
process may take as long as two business days. Applicants are strongly encouraged to check the status of
their application to ensure that submission of their package has been completed and no submission errors
have occurred. Applicants also are strongly encouraged to allocate ample time for filing to guarantee that
their application can be submitted and validated by the deadline published in the FOA. Non-validated
applications will not be accepted after the published application deadline date.
If you do not receive a “validation” e-mail within two business days of application submission, please
contact www.grants.gov. For instructions on how to track your application, refer to the e-mail message
generated at the time of application submission or the Grants.gov Online User Guide.
http:// www.grants.gov/help/html/help/index.htm? callingApp=custom#t= Get_Started%2FGet_Started. htm
d. Technical Difficulties: If technical difficulties are encountered at www.grants.gov, applicants should
contact Customer Service at www.grants.gov. The www.grants.gov Contact Center is available 24 hours a
day, 7 days a week, except federal holidays. The Contact Center is available by phone at
1-800-518-4726Image Description: or by e-mail at support@grants.gov. Application submissions sent by
e-mail or fax, or on CDs or thumb drives will not be accepted. Please note that www.grants.gov is managed
by HHS.
e. Paper Submission: If technical difficulties are encountered at www.grants.gov, applicants should call
the www.grants.gov Contact Center at 1-800-518-4726Image Description: or e-mail them
at support@grants.gov for assistance. After consulting with the Contact Center, if the technical difficulties
remain unresolved and electronic submission is not possible, applicants may e-mail CDC GMO/GMS, before
the deadline, and request permission to submit a paper application. Such requests are handled on a
case-by-case basis.
An applicant’s request for permission to submit a paper application must:
1. Include the www.grants.gov case number assigned to the inquiry
2. Describe the difficulties that prevent electronic submission and the efforts taken with
the www.grants.gov Contact Center to submit electronically; and
3. Be received via e-mail to the GMS/GMO listed below at least three calendar days before the
application deadline. Paper applications submitted without prior approval will not be considered.
If a paper application is authorized, OGS will advise the applicant of specific instructions for
submitting the application (e.g., original and two hard copies of the application by U.S. mail or express
delivery service).
E. Review and Selection Process
1. Review and Selection Process: Applications will be reviewed in three phases
25 of 42
a. Phase 1 Review
All applications will be initially reviewed for eligibility and completeness by CDC Office of Grants Services.
Complete applications will be reviewed for responsiveness by the Grants Management Officials and
Program Officials. Non-responsive applications will not advance to Phase II review. Applicants will be
notified that their applications did not meet eligibility and/or published submission requirements.
b. Phase II Review
A review panel will evaluate complete, eligible applications in accordance with the criteria below.
i. Approach
ii. Evaluation and Performance Measurement
iii. Applicant’s Organizational Capacity to Implement the Approach
Not more than thirty days after the Phase II review is completed, applicants will be notified electronically if
their application does not meet eligibility or published submission requirements.
i. Approach
Evaluate the extent to which the applicant:
Maximum Points:50
1) Describes conditions that exist and contribute to lead poisoning, such as homes built prior to 1978,
low-income or subsidized housing with known or suspected lead hazards; and percent of children with
elevated BLLS. (5points)
2) Justifies the need for this program within its geographic area and adequately describe sub-populations at
greatest risk for lead poisoning. (4 points)
3) Demonstrates strategies to implement a plan for blood lead testing of children less than 6 years (72
months) of age.
Does the plan include an emphasis on universal testing of Medicaid-enrolled children. (5 Points)
4) Demonstrates strategies to implement or improve blood lead surveillance.
Does the applicant describe the establishment of or the operation of the Healthy Homes and Lead
Poisoning Surveillance System or an equivalent surveillance system that will collect, compile, and
track blood lead data and lead hazards data? (10 points)
Does the applicant describe how they will conduct analyses of surveillance data? (8 Points)
Does the applicant describe a plan to ensure that data is submitted to CDC quarterly? (2 Points)
Does the applicant describe a surveillance reporting system and dissemination plan? Does the plan
include how data will be: (5 Points)
Collected?
Evaluated?
Reported?
Shared with partners?
Disseminated to the public?
5) Demonstrates the capacity to strengthen population-based interventions.
Does the applicant describe building or maintaining collaborative relationships with community,
local, and state partners and stakeholders to address priority childhood lead poisoning prevention
challenges and opportunities? (1 Point)
Does the applicant describe a plan to educate public, partners, and stakeholders about lead-related
issues? (1 Point)
Does the applicant describe a plan to develop and conduct outreach and education to lead workforce,
partners, and other stakeholders? (1 Point)
26 of 42
partners, and other stakeholders? (1 Point)
Does the applicant have data-sharing agreements in place with housing, code enforcement, and other
health agencies? (1 Point)
Does the applicant describe their ability to use surveillance data to target appropriate
population-based, primary prevention interventions in high risk areas by collaborating with housing
rehabilitation, housing and health code enforcement, health care systems and early childhood and
other educational agencies? (1 Point)
6) Describes a process to identify lead-exposed children and link them to services.
Does the applicant describe a plan to identify lead exposed children and develop guidance for
follow-up care? (2 Points)
Does the applicant describe a plan to track timeliness and efficacy of follow-up activities? (2 Points)
Does the applicant describe a plan to provide education and outreach to parents and providers of
lead-exposed children? (2 Points)
ii. Evaluation and Performance Measurement
Evaluate the extent to which the applicant:
Maximum Points:25
1) Presents performance measures and demonstrates how they will implement them. (15 Points)
2) Includes a work plan that is aligned with the strategies/activities and outcomes of this FOA. (10 Points)
iii. Applicant's Organizational Capacity to Implement the Approach
Evaluate the extent to which the applicant:
Maximum Points:25
1) Provides a sustainment and staffing plan of current and potential personnel, including qualifications and
specific experience as it relates to the requirements set forth in this announcement (e.g., CVs for staff).
Specifically, the plan should include steps to receive, analyze, monitor and report data to CDC, and conduct
prevention activities to reduce lead exposures. If applicable, provides a plan for identifying and hiring
qualified applicants on a timely basis. (15 Points)
2) Demonstrates that adequate staffing are available to perform activities outlined section in the FOA. (10
Points)
Budget
Reviewed, but not scored:
The budget will be evaluated for the extent to which it is reasonable, clearly justified, and consistent with
the intended use of the cooperative agreement funds. The applicant shall describe and indicate the
availability of facilities and equipment necessary to carry out this project.
If the applicant requests indirect costs in the budget, a copy of the indirect cost rate agreement is required.
If the indirect cost rate is a provisional rate, the agreement should be less than 12 months of age. The
indirect cost rate agreement should be uploaded as a PDF file with “Other Attachment Forms” when
submitting via Grants.gov.
The applicant can obtain guidance for completing a detailed justified budget on the CDC website at http
://www.cdc.gov/funding .
c. Phase III Review
27 of 42
In Year 1 of this FOA, CDC will prioritize applicants that have not already received funding for childhood
lead poisoning prevention activities under CDC-RFA-EH14-1408PPHF14 in FY2017 and may fund out of
rank order. Grantees receiving Year 4 Supplemental funding under CDC-RFA-EH14-1408PPHF14 will not
receive Year 1 funding under CDC-RFA-EH17-1701PPHF17.
Review of risk posed by applicants.
Prior to making a Federal award, CDC is required by 31 U.S.C. 3321 and 41 U.S.C. 2313 to review
information available through any OMB-designated repositories of government-wide eligibility qualification
or financial integrity information as appropriate. See also suspension and debarment requirements at 2 CFR
parts 180 and 376.
In accordance 41 U.S.C. 2313, CDC is required to review the non-public segment of the OMB-designated
integrity and performance system accessible through SAM (currently the Federal Awardee Performance and
Integrity Information System (FAPIIS)) prior to making a Federal award where the Federal share is expected
to exceed the simplified acquisition threshold, defined in 41 U.S.C. 134, over the period of performance. At
a minimum, the information in the system for a prior Federal award recipient must demonstrate a satisfactory
record of executing programs or activities under Federal grants, cooperative agreements, or procurement
awards; and integrity and business ethics. CDC may make a Federal award to a recipient who does not fully
meet these standards, if it is determined that the information is not relevant to the current Federal award
under consideration or there are specific conditions that can appropriately mitigate the effects of the
non-Federal entity's risk in accordance with 45 CFR §75.207.
CDC’s framework for evaluating the risks posed by an applicant may incorporate results of the evaluation of
the applicant's eligibility or the quality of its application. If it is determined that a Federal award will be
made, special conditions that correspond to the degree of risk assessed may be applied to the Federal award.
The evaluation criteria is described in this funding opportunity announcement.
In evaluating risks posed by applicants, CDC will use a risk-based approach and may consider any items
such as the following:
(1) Financial stability;
(2) Quality of management systems and ability to meet the management standards prescribed in this part;
(3) History of performance. The applicant's record in managing Federal awards, if it is a prior recipient of
Federal awards, including timeliness of compliance with applicable reporting requirements, conformance to
the terms and conditions of previous Federal awards, and if applicable, the extent to which any previously
awarded amounts will be expended prior to future awards;
(4) Reports and findings from audits performed under subpart F 45 CFR 75 or the reports and findings of any
other available audits; and
(5) The applicant's ability to effectively implement statutory, regulatory, or other requirements imposed on
non-Federal entities.
CDC must comply with the guidelines on government-wide suspension and debarment in 2 CFR part 180,
and require non-Federal entities to comply with these provisions. These provisions restrict Federal awards,
subawards and contracts with certain parties that are debarred, suspended or otherwise excluded from or
ineligible for participation in Federal programs or activities.
2. Announcement and Anticipated Award Dates
Announcement date: 3/20/2017; Anticipated Award Date: 9/30/2017
F. Award Administration Information
28 of 42
1. Award Notices
Awardees will receive an electronic copy of the Notice of Award (NOA) from CDC OGS. The NOA shall
be the only binding, authorizing document between the awardee and CDC. The NOA will be signed by an
authorized GMO and emailed to the Awardee Business Officer listed in application and the Program
Director.
Any applicant awarded funds in response to this FOA will be subject to the DUNS, SAM Registration, and
Federal Funding Accountability And Transparency Act Of 2006 (FFATA) requirements.
Unsuccessful applicants will receive notification of these results by e-mail with delivery receipt or by U.S.
mail.
2. Administrative and National Policy Requirements
Awardees must comply with the administrative and public policy requirements outlined in 45 CFR Part
75 and the HHS Grants Policy Statement, as appropriate.
Brief descriptions of relevant provisions are available
at http://www.cdc.gov/grants/additionalrequirements/index.html#ui-id-17.
The HHS Grants Policy Statement is available
at http://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf.
For more information on the CFR visit http://www. access.gpo.gov/ nara/cfr/cfr-table- search.html
3. Reporting
Reporting provides continuous program monitoring and identifies successes and challenges that awardees
encounter throughout the project period. Also, reporting is a requirement for awardees who want to apply for
yearly continuation of funding. Reporting helps CDC and awardees because it:
Helps target support to awardees;
Provides CDC with periodic data to monitor awardee progress toward meeting the FOA outcomes and
overall performance;
Allows CDC to track performance measures and evaluation findings for continuous quality and
program improvement throughout the project period and to determine applicability of evidence-based
approaches to different populations, settings, and contexts; and
Enables CDC to assess the overall effectiveness and influence of the FOA.
The table below summarizes required and optional reports. All required reports must be sent electronically to
GMS listed in the “Agency Contacts” section of the FOA copying the CDC Project Officer.
Report
When?
Required?
Awardee Evaluation and
6 months into award.
Yes
Performance
Measurement
Plan including Data
Management Plan (DMP)
29 of 42
Surveillance Data Reports Quarterly reports due by Yes
end of following quarter
for each budget period:
March 31, June 30,
September 30, December
31.
Data on PPHF
Performance Measures
Semi-annual in PPHF
Yes
Recipient Reporting
System (PRRS): January
31 and July 31 for each
budget period, plus
closeout January 31, 2021.
Annual Performance
Report
No later than 120 days
Yes
before end of budget
period. Serves as yearly
continuation application.
(APR)
Federal Financial
Reporting
90 days after end of
calendar
Forms
quarter in which budget
period
Yes
ends
Final Performance and
Yes
Financial Report
90 days after end of
project period.
Payment Management
System
Quarterly reports due
January
Yes
(PMS) Reporting
31, 2018; April 30, 2018;
July
31, 2018; October 31,
2018;
January 31, 2019.
a. Awardee Evaluation and Performance Measurement Plan (required)
With support from CDC, awardees must elaborate on their initial applicant evaluation and performance
measurement plan. This plan must be no more than 20 pages; awardees must submit the plan 6 months into
the award. HHS/CDC will review and approve the recipient’s monitoring and evaluation plan to ensure that
it is appropriate for the activities to be undertaken as part of the agreement, for compliance with the
monitoring and evaluation guidance established by HHS/CDC, or other guidance otherwise applicable to this
Agreement.
Awardee Evaluation and Performance Measurement Plan (required): This plan should provide additional
detail on the following:
Performance Measurement
• Performance measures and targets
• The frequency that performance data are to be collected.
30 of 42
• The frequency that performance data are to be collected.
• How performance data will be reported.
• How quality of performance data will be assured.
• How performance measurement will yield findings to demonstrate progress towards achieving FOA goals
(e.g., reaching target populations or achieving expected outcomes).
• Dissemination channels and audiences.
• Other information requested as determined by the CDC program.
Evaluation
• The types of evaluations to be conducted (e.g. process or outcome evaluations).
• The frequency that evaluations will be conducted.
• How evaluation reports will be published on a publically available website.
• How evaluation findings will be used to ensure continuous quality and program improvement.
• How evaluation will yield findings to demonstrate the value of the FOA (e.g., effect on improving public
health outcomes, effectiveness of FOA, cost-effectiveness or cost-benefit).
• Dissemination channels and audiences.
HHS/CDC or its designee will also undertake monitoring and evaluation of the defined activities within the
agreement. The recipient must ensure reasonable access by HHS/CDC or its designee to all necessary sites,
documentation, individuals and information to monitor, evaluate and verify the appropriate implementation
the activities and use of HHS/CDC funding under this Agreement.
b. Annual Performance Report (APR) (required)
The awardee must submit the APR via www.Grantsolutions.gov no later than120 days prior to the end of the
budget period. This report must not exceed 45 pages excluding administrative reporting. Attachments are not
allowed, but weblinks are allowed.
This report must include the following:
Performance Measures: Awardees must report on performance measures for each budget period and
update measures, if needed.
Evaluation Results: Awardees must report evaluation results for the work completed to date
(including findings from process or outcome evaluations).
Work Plan: Awardees must update work plan each budget period to reflect any changes in project
period outcomes, activities, timeline, etc.
Successes
Awardees must report progress on completing activities and progress towards achieving the
project period outcomes described in the logic model and work plan.
Awardees must describe any additional successes (e.g. identified through evaluation results or
lessons learned) achieved in the past year.
Awardees must describe success stories.
Challenges
Awardees must describe any challenges that hindered or might hinder their ability to complete
the work plan activities and achieve the project period outcomes.
Awardees must describe any additional challenges (e.g., identified through evaluation results or
lessons learned) encountered in the past year.
CDC Program Support to Awardees
Awardees must describe how CDC could help them overcome challenges to complete activities
in the work plan and achieving project period outcomes.
Administrative Reporting (No page limit)
SF-424A Budget Information-Non-Construction Programs.
31 of 42
Budget Narrative – Must use the format outlined in "Content and Form of Application
Submission, Budget Narrative" section.
Indirect Cost Rate Agreement.
In addition, the awardees should complete the following requirements in their Annual Performance
Report:
Requirement 1 - Complete annual web-based Awardee Lead Profile Assessment. CDC will provide
the link to the assessment upon request. The purpose of the assessment is to identify 1) jurisdictional
legal frameworks governing CDC-funded childhood lead poisoning prevention programs in the United
States, and 2) strategies for implementing childhood lead poisoning prevention activities in the United
States.
Requirement 2 - Complete the Performance Measures reporting document to state progress toward
short-term outcomes of this cooperative agreement. Baseline and Target figures must be documented
during the first reporting in 2018. CDC will provide this document upon request.
Requirement 3 - In the narrative, describe progress to date, and address the following elements
related to this cooperative agreement’s short-term outcomes:
1. Increased numbers of children less than 6 years (less than 72 months) of age tested for blood
lead.
Describe the criteria used to identify high-risk geographic areas.
List the targeted high-risk geographic areas that have been identified.
1. To the extent possible, provide the number of children less than 6 years (less than
72 months) of age that live in high-risk geographic areas.
Describe the criteria used to identify children at-risk for lead poisoning and targeted for
lead poisoning prevention interventions.
List the at-risk populations that have been identified using recent surveillance data
1. Provide the number of children less than 6 years (less than 72 months) of age
considered at-risk.
2. Improved availability and use of data that leads to improved identification of geographic areas
and populations at high risk for lead exposure.
Describe the current surveillance system and its capacity to collect electronic laboratory
results, store demographic and housing variables (in addition to blood lead test results),
prepare reports for submission to CDC, and track referrals for follow-up services.
Describe current resources used to analyze and report data.
Describe data from other organizations and agencies used to analyze and report data (ex.
census, tax assessor).
Describe how data is reported to partners and other stakeholders.
3. Increased ability to target interventions (e.g. education and outreach) to high-risk geographic
areas and populations.
List partner organizations and institutions engaged in brainstorming, strategizing,
planning, implementing, or evaluating interventions for lead poisoning prevention in
targeted geographic areas.
1. Describe each partner’s level of engagement
List partner organizations and institutions engaged in brainstorming, strategizing,
planning, implementing, or evaluating interventions for lead poisoning prevention for
targeted at-risk populations (to include low-income and immigrant/refugee children)
1. Describe each partner’s level of engagement
Describe challenges and opportunities associated with leveraging partnerships to target
interventions.
4. Increased knowledge and awareness among the lay public, public health professionals,
childhood lead prevention workforce members, and other partners and stakeholders about
32 of 42
childhood lead poisoning and prevention interventions through tailored education and outreach.
Describe any new avenues of support from stakeholders for lead poisoning prevention
interventions, screening test increases, and lead source control and elimination.
5. Increased identification of lead-exposed children who receive appropriate linkages to
recommended follow-up services.
List common referred follow-up services for lead-exposed children and describe the
circumstances that initiate each type of referral. Follow-up services can include
additional blood lead tests, visual inspections of potential exposure sites, home
assessments, risk assessments, home remediation and repair, social service outreach,
community resource connections, nutrition services, medical homes, developmental
tracking and special education services, and the like.
1. Describe the current process (or plans for a future process) to ensure tracking of
referrals made and received for lead-exposed children.
Requirement 4 – Submit a success story based on one of the activities in your annual report. A
concise success story has one clearly defined issue or problem, describes an intervention taken to
address that issue, and tells the impact or outcome of that intervention. Examples are available at the
bottom of the internet page at https://www.cdc.gov/nceh/lead/programs/default.htm, Use the guidance
below to guide the creation of their success story.
Success Story Criteria
Title
Does the title:
1. Capture the attention of the reader?
2. Avoid acronyms?
3. Contain a verb?
Issue
Does the issue statement:
1. Have a strong lead sentence?
2. Provide local, regional, or state information about the issue?
3. Tie the burden (health, training, or threat) to a cost burden?
4. Specify the affected population?
5. Provide an emotional hook?
6. Present a clear, concise statement about a single issue?
Intervention
Does the intervention statement:
1. Have a strong lead sentence that transitions the issue section to the intervention section?
2. Identify who conducted the intervention?
3. Identify where and when the intervention occurred?
4. Specify the steps of the intervention?
Impact
Does the impact statement:
1. Give specific outcomes? (e.g., money saved, change in health outcomes, number of
people affected)
2. Avoid broad, sweeping statements?
33 of 42
3. Provide conclusions that wrap up the story in a convincing manner?
General Formatting
Does the success story:
1. Avoid wordiness, passive language, and grammatical and spelling errors?
2. Use terms that are understood by a non-public health audience? (avoids jargon)
3. Use one page if possible?
4. Use bullets where possible?
5. Include contact information?
Awardee Evaluation and Performance Measurement Plan: Awardees shall submit a detailed Evaluation
and Performance Measurement Plan within 6 months after award, including a Data Management Plan (DMP)
that aligns with the CDC’s DMP for blood lead surveillance. Awardees will receive the CDC DMP
following the review of the applications.
Surveillance Data Reports: Awardees shall submit quarterly reports due by end of following quarter for
each budget period via CDC secure encrypted File Transfer Protocol (FTP) site.
PPHF Performance Measures: Awardees shall submit semi-annual reports via the PPHF Recipient
Reporting System (PRRS).
The awardees must submit the Annual Performance Report via www.Grantsolutions.gov no later than 120
days prior to the end of the budget period.
c. Performance Measure Reporting (optional)
CDC programs may require more frequent reporting of performance measures than annually in the APR. If
this is the case, CDC programs must specify reporting frequency, data fields, and format for awardees at the
beginning of the award period.
d. Federal Financial Reporting (FFR) (required)
The annual FFR form (SF-425) is required and must be submitted 90 days after the end of the budget period.
The report must include only those funds authorized and disbursed during the timeframe covered by the
report. The final FFR must indicate the exact balance of unobligated funds, and may not reflect any
unliquidated obligations. There must be no discrepancies between the final FFR expenditure data and the
Payment Management System’s (PMS) cash transaction data. Failure to submit the required information by
the due date may adversely affect the future funding of the project. If the information cannot be provided by
the due date, awardees are required to submit a letter of explanation to OGS and include the date by which
the Grants Officer will receive information.
The FFR must be completed by Awardees in www.grantsolutions.gov.
e. Final Performance and Financial Report (required)
This report is due 90 days after the end of the project period. CDC programs must indicate that this report
should not exceed 40 pages. This report covers the entire project period and can include information
previously reported in APRs. At a minimum, this report must include the following:
Performance Measures – Awardees must report final performance data for all process and outcome
34 of 42
performance measures.
Evaluation Results – Awardees must report final evaluation results for the project period for any
evaluations conducted.
Impact/Results/Success Stories – Awardees must use their performance measure results and their
evaluation findings to describe the effects or results of the work completed over the project period, and
can include some success stories.
A final Data Management Plan that includes the location of the data collected during the funded
period, for example, repository name and link data set(s)
Additional forms as described in the Notice of Award (e.g., Equipment Inventory Report, Final
Invention Statement).
Awardees must email their report to the CDC Project Officer and the Grants Management Specialist listed in
the Agency Contacts section of this FOA.
4. Federal Funding Accountability and Transparency Act of 2006 (FFATA)
Federal Funding Accountability and Transparency Act of 2006 (FFATA), P.L. 109–282, as amended by
section 6202 of P.L. 110–252 requires full disclosure of all entities and organizations receiving Federal
funds including awards, contracts, loans, other assistance, and payments through a single publicly accessible
Web site, http://www.USASpending.gov.
Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the
law require information to be collected and reported by applicants: 1) information on executive
compensation when not already reported through the SAM, and 2) similar information on all
sub-awards/subcontracts/consortiums over $25,000.
For the full text of the requirements under the FFATA and HHS guidelines, go to:
https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf,
https://www. fsrs.gov/documents /ffata_legislation_ 110_252.pdf
http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.
5. Reporting of Foreign Taxes (International/Foreign projects only)
A. Valued Added Tax (VAT) and Customs Duties – Customs and import duties, consular fees, customs
surtax, valued added taxes, and other related charges are hereby authorized as an allowable cost for costs
incurred for non-host governmental entities operating where no applicable tax exemption exists. This waiver
does not apply to countries where a bilateral agreement (or similar legal document) is already in place
providing applicable tax exemptions and it is not applicable to Ministries of Health. Successful applicants
will receive information on VAT requirements via their Notice of Award.
B. The U.S. Department of State requires that agencies collect and report information on the amount of taxes
assessed, reimbursed and not reimbursed by a foreign government against commodities financed with funds
appropriated by the U.S. Department of State, Foreign Operations and Related Programs Appropriations Act
(SFOAA) (“United States foreign assistance funds”). Outlined below are the specifics of this requirement:
1) Annual Report: The grantee must submit a report on or before November 16 for each foreign country on
the amount of foreign taxes charged, as of September 30 of the same year, by a foreign government on
commodity purchase transactions valued at 500 USD or more financed with United States foreign assistance
funds under this grant during the prior United States fiscal year (October 1 – September 30), and the amount
reimbursed and unreimbursed by the foreign government. [Reports are required even if the grantee did not
pay any taxes during the reporting period.]
2) Quarterly Report: The grantee must quarterly submit a report on the amount of foreign taxes charged by a
foreign government on commodity purchase transactions valued at 500 USD or more financed with United
35 of 42
States foreign assistance funds under this grant. This report shall be submitted no later than two weeks
following the end of each quarter: April 15, July 15, October 15 and January 15.
3) Terms: For purposes of this clause:
“Commodity” means any material, article, supplies, goods, or equipment;
“Foreign government” includes any foreign government entity;
“Foreign taxes” means value-added taxes and custom duties assessed by a foreign government on a
commodity. It does not include foreign sales taxes.
4) Where: Submit the reports to the Director and Deputy Director of the CDC office in the country(ies) in
which you are carrying out the activities associated with this cooperative agreement. In countries where there
is no CDC office, send reports to VATreporting@cdc.gov.
5) Contents of Reports: The reports must contain:
a. grantee name;
b. contact name with phone, fax, and e-mail;
c. agreement number(s) if reporting by agreement(s);
d. reporting period;
e. amount of foreign taxes assessed by each foreign government;
f. amount of any foreign taxes reimbursed by each foreign government;
g. amount of foreign taxes unreimbursed by each foreign government.
6) Subagreements. The grantee must include this reporting requirement in all applicable subgrants and other
subagreements.
G. Agency Contacts
CDC encourages inquiries concerning this FOA.
Program Office Contact
For programmatic technical assistance, contact:
Kimball Credle, Project Officer
Department of Health and Human Services
Centers for Disease Control and Prevention
National Center for Environmental Health
Division of Emergency and Environmental Health Services
Telephone: 770.488.3643
Email: kfc2@cdc.gov
Grants Staff Contact
For financial, awards management, or budget assistance, contact:
Victoria McBee, Grants Management Specialist
Department of Health and Human Services
Office of Grants Services
Grants Management Specialist
36 of 42
Grants Management Specialist
Time Solutions, LLC Contractor
Department of Health and Human Services
Centers for Disease Control and Prevention
Office of the Chief Operating Officer
Office of Financial Resources
Office of Grant Services
Telephone: 770.488.2825
Email: yig9@cdc.gov
For assistance with submission difficulties related to www.grants.gov, contact the Contact Center by phone
at 1-800-518-4726Image Description: .
Hours of Operation: 24 hours a day, 7 days a week, except on federal holidays.
For all other submission questions, contact:
Technical Information Management Section
Department of Health and Human Services
CDC Office of Financial Resources
Office of Grants Services
2920 Brandywine Road, MS E-14
Atlanta, GA 30341
Telephone: 770-488-2700Image Description:
E-mail: ogstims@cdc.gov
CDC Telecommunications for persons with hearing loss is available at: TTY
1-888-232-6348Image Description:
H. Other Information
Following is a list of acceptable attachments applicants can upload as PDF files as part of their application
at www.grants.gov. Applicants may not attach documents other than those listed; if other documents are
attached, applications will not be reviewed.
Project Abstract
Project Narrative
Budget Narrative
CDC Assurances and Certifications
Report on Programmatic, Budgetary and Commitment Overlap
Table of Contents for Entire Submission
For international FOAs:
SF424
SF424A
Funding Preference Deliverables
Optional attachments, as determined by CDC programs:
37 of 42
Optional attachments, as determined by CDC programs:
Resumes / CVs
Position descriptions
Letters of Support
Indirect Cost Rate, if applicable
Memorandum of Agreement (MOA)
Memorandum of Understanding (MOU)
Bona Fide Agent status documentation, if applicable
CDC/NCEH/Lead website: www.cdc.gov/nceh/lead/about/program.htm
Following is a list of acceptable attachments that applicants can upload as PDF files as part of their
applications at www.grants.gov . Applicants may not attach documents other than those listed; if other
documents are attached, applications will not be reviewed.
Project Abstract
Project Narrative
Budget Narrative
CDC Assurances and Certifications
Work Plan
Table of Contents for Entire Submission
Resumes/CVs
Organizational Charts
Nonprofit Organization IRS Status Forms, if applicable
Indirect Cost Rate, if applicable
Memorandum of Agreement (MOA)
Memorandum of Understanding (MOU)
Bona Fide Agent Status Documentation, if applicable
I. Glossary
Activities: The actual events or actions that take place as a part of the program.
Administrative and National Policy Requirements, Additional Requirements (ARs): Administrative
requirements found in 45 CFR Part 75 and other requirements mandated by statute or CDC policy. All ARs
are listed in the Template for CDC programs. CDC programs must indicate which ARs are relevant to the
FOA; awardees must comply with the ARs listed in the FOA. To view brief descriptions of relevant
provisions, see http:// www.cdc.gov/ grants/ additional requirements/ index.html. Note that 2 CFR 200
supersedes the administrative requirements (A-110 & A-102), cost principles (A-21, A-87 & A-122) and
audit requirements (A-50, A-89 & A-133).
Approved but Unfunded: Approved but unfunded refers to applications recommended for approval during
the objective review process; however, they were not recommended for funding by the program office and/or
the grants management office.
Award: Financial assistance that provides support or stimulation to accomplish a public purpose. Awards
include grants and other agreements (e.g., cooperative agreements) in the form of money, or property in lieu
of money, by the federal government to an eligible applicant.
Budget Period or Budget Year: The duration of each individual funding period within the project period.
Traditionally, budget periods are 12 months or 1 year.
Carryover: Unobligated federal funds remaining at the end of any budget period that, with the approval of
the GMO or under an automatic authority, may be carried over to another budget period to cover allowable
costs of that budget period either as an offset or additional authorization. Obligated but liquidated funds are
not considered carryover.
38 of 42
not considered carryover.
Catalog of Federal Domestic Assistance (CFDA): A government-wide compendium published by the
General Services Administration (available on-line in searchable format as well as in printable format as a
.pdf file) that describes domestic assistance programs administered by the Federal Government.
CFDA Number: A unique number assigned to each program and FOA throughout its lifecycle that enables
data and funding tracking and transparency.
CDC Assurances and Certifications: Standard government-wide grant application forms.
Competing Continuation Award: A financial assistance mechanism that adds funds to a grant and adds one
or more budget periods to the previously established project period (i.e., extends the “life” of the award).
Continuous Quality Improvement: A system that seeks to improve the provision of services with an
emphasis on future results.
Contracts: An award instrument used to acquire (by purchase, lease, or barter) property or services for the
direct benefit or use of the Federal Government.
Cooperative Agreement: A financial assistance award with the same kind of interagency relationship as a
grant except that it provides for substantial involvement by the federal agency funding the award. Substantial
involvement means that the recipient can expect federal programmatic collaboration or participation in
carrying out the effort under the award.
Cost Sharing or Matching: Refers to program costs not borne by the Federal Government but by the
awardees. It may include the value of allowable third-party, in-kind contributions, as well as expenditures by
the awardee.
Direct Assistance: A financial assistance mechanism, which must be specifically authorized by statute,
whereby goods or services are provided to recipients in lieu of cash. DA generally involves the assignment
of federal personnel or the provision of equipment or supplies, such as vaccines. DA is primarily used to
support payroll and travel expenses of CDC employees assigned to state, tribal, local, and territorial (STLT)
health agencies that are recipients of grants and cooperative agreements. Most legislative authorities that
provide financial assistance to STLT health agencies allow for the use of DA. http:// www.cdc.gov /grants
/additionalrequirements /index.html.
DUNS: The Dun and Bradstreet (D&B) Data Universal Numbering System (DUNS) number is a nine-digit
number assigned by Dun and Bradstreet Information Services. When applying for Federal awards or
cooperative agreements, all applicant organizations must obtain a DUNS number as the Universal Identifier.
DUNS number assignment is free. If requested by telephone, a DUNS number will be provided immediately
at no charge. If requested via the Internet, obtaining a DUNS number may take one to two days at no charge.
If an organization does not know its DUNS number or needs to register for one, visit Dun & Bradstreet at
http://fedgov.dnb.com/ webform/displayHomePage.do.
Evaluation (program evaluation): The systematic collection of information about the activities,
characteristics, and outcomes of programs (which may include interventions, policies, and specific projects)
to make judgments about that program, improve program effectiveness, and/or inform decisions about future
program development.
Evaluation Plan: A written document describing the overall approach that will be used to guide an
evaluation, including why the evaluation is being conducted, how the findings will likely be used, and the
design and data collection sources and methods. The plan specifies what will be done, how it will be done,
who will do it, and when it will be done. The FOA evaluation plan is used to describe how the awardee
and/or CDC will determine whether activities are implemented appropriately and outcomes are achieved.
Federal Funding Accountability and Transparency Act of 2006 (FFATA): Requires that information
about federal awards, including awards, contracts, loans, and other assistance and payments, be available to
the public on a single website at www.USAspending.gov.
Fiscal Year: The year for which budget dollars are allocated annually. The federal fiscal year starts October
1 and ends September 30.
Grant: A legal instrument used by the federal government to transfer anything of value to a recipient for
public support or stimulation authorized by statute. Financial assistance may be money or property. The
definition does not include a federal procurement subject to the Federal Acquisition Regulation; technical
39 of 42
assistance (which provides services instead of money); or assistance in the form of revenue sharing, loans,
loan guarantees, interest subsidies, insurance, or direct payments of any kind to a person or persons. The
main difference between a grant and a cooperative agreement is that in a grant there is no anticipated
substantial programmatic involvement by the federal government under the award.
Grants.gov: A "storefront" web portal for electronic data collection (forms and reports) for federal
grant-making agencies at www.grants.gov.
Grants Management Officer (GMO): The individual designated to serve as the HHS official responsible
for the business management aspects of a particular grant(s) or cooperative agreement(s). The GMO serves
as the counterpart to the business officer of the recipient organization. In this capacity, the GMO is
responsible for all business management matters associated with the review, negotiation, award, and
administration of grants and interprets grants administration policies and provisions. The GMO works closely
with the program or project officer who is responsible for the scientific, technical, and programmatic aspects
of the grant.
Grants Management Specialist (GMS): A federal staff member who oversees the business and other
non-programmatic aspects of one or more grants and/or cooperative agreements. These activities include, but
are not limited to, evaluating grant applications for administrative content and compliance with regulations
and guidelines, negotiating grants, providing consultation and technical assistance to recipients, post-award
administration and closing out grants.
Health Disparities: Differences in health outcomes and their determinants among segments of the
population as defined by social, demographic, environmental, or geographic category.
Health Equity: Striving for the highest possible standard of health for all people and giving special attention
to the needs of those at greatest risk of poor health, based on social conditions.
Health Inequities: Systematic, unfair, and avoidable differences in health outcomes and their determinants
between segments of the population, such as by socioeconomic status (SES), demographics, or geography.
Healthy People 2020: National health objectives aimed at improving the health of all Americans by
encouraging collaboration across sectors, guiding people toward making informed health decisions, and
measuring the effects of prevention activities.
Inclusion: Both the meaningful involvement of a community’s members in all stages of the program process
and the maximum involvement of the target population that the intervention will benefit. Inclusion ensures
that the views, perspectives, and needs of affected communities, care providers, and key partners are
considered.
Indirect Costs: Costs that are incurred for common or joint objectives and not readily and specifically
identifiable with a particular sponsored project, program, or activity; nevertheless, these costs are necessary
to the operations of the organization. For example, the costs of operating and maintaining facilities,
depreciation, and administrative salaries generally are considered indirect costs.
Intergovernmental Review: Executive Order 12372 governs applications subject to Intergovernmental
Review of Federal Programs. This order sets up a system for state and local governmental review of
proposed federal assistance applications. Contact the state single point of contact (SPOC) to alert the SPOC
to prospective applications and to receive instructions on the State’s process. Visit the following web address
to get the current SPOC list: http://www.whitehouse.gov/omb/ grants_spoc/.
Letter of Intent (LOI): A preliminary, non-binding indication of an organization’s intent to submit an
application.
Lobbying: Direct lobbying includes any attempt to influence legislation, appropriations, regulations,
administrative actions, executive orders (legislation or other orders), or other similar deliberations at any
level of government through communication that directly expresses a view on proposed or pending
legislation or other orders, and which is directed to staff members or other employees of a legislative body,
government officials, or employees who participate in formulating legislation or other orders. Grass roots
lobbying includes efforts directed at inducing or encouraging members of the public to contact their elected
representatives at the federal, state, or local levels to urge support of, or opposition to, proposed or pending
legislative proposals.
Logic Model: A visual representation showing the sequence of related events connecting the activities of a
40 of 42
program with the programs’ desired outcomes and results.
Maintenance of Effort: A requirement contained in authorizing legislation, or applicable regulations that a
recipient must agree to contribute and maintain a specified level of financial effort from its own resources or
other non-government sources to be eligible to receive federal grant funds. This requirement is typically
given in terms of meeting a previous base-year dollar amount.
Memorandum of Understanding (MOU) or Memorandum of Agreement (MOA): Document that
describes a bilateral or multilateral agreement between parties expressing a convergence of will between the
parties, indicating an intended common line of action. It is often used in cases where the parties either do not
imply a legal commitment or cannot create a legally enforceable agreement.
Nonprofit Organization: Any corporation, trust, association, cooperative, or other organization that is
operated primarily for scientific, educational, service, charitable, or similar purposes in the public interest; is
not organized for profit; and uses net proceeds to maintain, improve, or expand the operations of the
organization. Nonprofit organizations include institutions of higher educations, hospitals, and tribal
organizations (that is, Indian entities other than federally recognized Indian tribal governments).
Notice of Award (NoA): The official document, signed (or the electronic equivalent of signature) by a
Grants Management Officer that: (1) notifies the recipient of the award of a grant; (2) contains or references
all the terms and conditions of the grant and Federal funding limits and obligations; and (3) provides the
documentary basis for recording the obligation of Federal funds in the HHS accounting system.
Objective Review: A process that involves the thorough and consistent examination of applications based
on an unbiased evaluation of scientific or technical merit or other relevant aspects of the proposal. The
review is intended to provide advice to the persons responsible for making award decisions.
Outcome: The results of program operations or activitIes; the effects triggered by the program. For
example, increased knowledge, changed attitudes or beliefs, reduced tobacco use, reduced morbidity and
mortality.
Performance Measurement: The ongoing monitoring and reporting of program accomplishments,
particularly progress toward pre-established goals, typically conducted by program or agency management.
Performance measurement may address the type or level of program activities conducted (process), the direct
products and services delivered by a program (outputs), or the results of those products and services
(outcomes). A “program” may be any activity, project, function, or policy that has an identifiable purpose or
set of objectives.
Plain Writing Act of 2010: The Plain Writing Act of 2010 requires that federal agencies use clear
communication that the public can understand and use. FOAs must be written in clear, consistent language
so that any reader can understand expectations and intended outcomes of the funded program. CDC
programs should use FOA plain writing tips when writing FOAs.
Program Strategies: Strategies are groupings of related activities, usually expressed as general headers
(e.g., Partnerships, Assessment, Policy) or as brief statements (e.g., Form partnerships, Conduct assessments,
Formulate policies).
Program Official: Person responsible for developing the FOA; can be either a project officer, program
manager, branch chief, division leader, policy official, center leader, or similar staff member.
Project Period Outcome: An outcome that will occur by the end of the FOA’s funding period.
Public Health Accreditation Board (PHAB): A nonprofit organization that works to promote and protect
the health of the public by advancing the quality and performance of public health departments in the U.S.
through national public health department accreditation http://www.phaboard.org.
Social Determinants of Health: Conditions in the environments in which people are born, live, learn, work,
play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks.
Statute: An act of the legislature; a particular law enacted and established by the will of the legislative
department of government, expressed with the requisite formalities. In foreign or civil law any particular
municipal law or usage, though resting for its authority on judicial decisions, or the practice of nations.
Statutory Authority: Authority provided by legal statute that establishes a federal financial assistance
program or award.
System for Award Management (SAM): The primary vendor database for the U.S. federal government.
41 of 42
SAM validates applicant information and electronically shares secure and encrypted data with federal
agencies' finance offices to facilitate paperless payments through Electronic Funds Transfer (EFT). SAM
stores organizational information, allowing www.grants.gov to verify identity and pre-fill organizational
information on grant applications.
Technical Assistance: Advice, assistance, or training pertaining to program development, implementation,
maintenance, or evaluation that is provided by the funding agency.
Work Plan: The summary of project period outcomes, strategies and activities, personnel and/or partners
who will complete the activities, and the timeline for completion. The work plan will outline the details of
all necessary activities that will be supported through the approved budget.
FOA-specific Glossary and Acronyms
GrantSolutions (The Grants Center of Excellence: www.grantsolutions.gov)
42 of 42
| File Type | application/pdf |
| File Modified | 2017-03-17 |
| File Created | 2017-03-17 |